» Articles » PMID: 20716669

Glutamate Receptor Ion Channels: Structure, Regulation, and Function

Overview
Journal Pharmacol Rev
Specialty Pharmacology
Date 2010 Aug 19
PMID 20716669
Citations 1678
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels containing an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore. Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells. These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system. Glutamate receptors are postulated to play important roles in numerous neurological diseases and have attracted intense scrutiny. The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel. In this review we discuss International Union of Basic and Clinical Pharmacology glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacology, allosteric modulation, mechanisms of gating and permeation, roles in normal physiological function, as well as the potential therapeutic use of pharmacological agents acting at glutamate receptors.

Citing Articles

Update on Neuroprotection after Traumatic Brain Injury.

Cook A, Michas M, Robbins B CNS Drugs. 2025; .

PMID: 40087248 DOI: 10.1007/s40263-025-01173-9.


Identification of Thyroid Genes Whose Expression Is Altered by Neonatal Irradiation in Rats.

Fujimoto N, Matsuu-Matsuyama M, Nakashima M Int J Mol Sci. 2025; 26(5).

PMID: 40076501 PMC: 11899105. DOI: 10.3390/ijms26051874.


Hypoxia tolerance determine differential gelsenicine-induced neurotoxicity between pig and mouse.

Huang C, Zuo M, Qi X, Gong M, Xu W, Meng S BMC Med. 2025; 23(1):156.

PMID: 40075370 PMC: 11905507. DOI: 10.1186/s12916-025-03984-5.


An efficient deep learning-based strategy to screen inhibitors for GluN1/GluN3A receptor.

Wang Z, Zeng Y, Sun J, Chen X, Wu H, Li Y Acta Pharmacol Sin. 2025; .

PMID: 40069493 DOI: 10.1038/s41401-025-01513-x.


An antidepressant mechanism underlying the allosteric inhibition of GluN2D-incorporated NMDA receptors at GABAergic interneurons.

Zhang J, Duan J, Li W, Wang X, Ren S, Ye L Sci Adv. 2025; 11(10):eadq0444.

PMID: 40043126 PMC: 11881904. DOI: 10.1126/sciadv.adq0444.


References
1.
Papadia S, Hardingham G . The dichotomy of NMDA receptor signaling. Neuroscientist. 2007; 13(6):572-9. PMC: 2830536. DOI: 10.1177/10738584070130060401. View

2.
Plant K, Pelkey K, Bortolotto Z, Morita D, Terashima A, McBain C . Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation. Nat Neurosci. 2006; 9(5):602-4. DOI: 10.1038/nn1678. View

3.
Burnashev N, Zhou Z, Neher E, Sakmann B . Fractional calcium currents through recombinant GluR channels of the NMDA, AMPA and kainate receptor subtypes. J Physiol. 1995; 485 ( Pt 2):403-18. PMC: 1158001. DOI: 10.1113/jphysiol.1995.sp020738. View

4.
Yuen E, Gu Z, Yan Z . Calpain regulation of AMPA receptor channels in cortical pyramidal neurons. J Physiol. 2007; 580(Pt 1):241-54. PMC: 2075435. DOI: 10.1113/jphysiol.2006.122754. View

5.
Albers G, Goldstein L, Hall D, Lesko L . Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA. 2001; 286(21):2673-82. DOI: 10.1001/jama.286.21.2673. View